On September 25, 2026, Lele Zhang disposed of 91,000 shares of Cutia Therapeutics - B on the SEHK open market at an average of HKD 0.9597 per share, involving about HKD 87,333. This was a forced sale by a securities company through a margin securities account.
Prior to the disposal, Lele Zhang's long position in Cutia Therapeutics - B was 26.65 million shares, representing 7.12%; following the disposal, the holding changed to 26.56 million shares, with the long position ratio falling to 7.09%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.